Syncom Formulations (India) Limited — Updates, 13-08-2026: General Updates
13-08-2026 | 05:48 pm
13-08-2026 | 05:48 pm
Syncom Formulations reported strong Q1 results: total income rose 8% to ₹133.36 Cr, and PAT surged 58% to ₹24.85 Cr. The Board proposes a ₹0.10 per share final dividend for FY26. Growth is driven by its ethical, prescription-led model and expanding market presence.
No comments yet. Be the first to comment!
